Work

Limited Long-Term Benefit of Upfront Autologous Stem Cell Transplant on Survival in Severe Renal Impairment in Multiple Myeloma in Novel Drug Era, a Retrospective Multi-Center Study in China

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-166445

Authors: Huixing Zhou, Yuan Jian, Weiwei Xie, Yuan Ren, Zhiyao Zhang, Guangzhong Yang, Chuanying Geng, Jing Jia, Wenming Chen, Jian Li, Wenrong Huang, Xinan Cen, Wen Gao

Institutions: Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Peking University First Hospital, Chinese People's Liberation Army, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310126192

FWCI:

Cites:

Cited by: 1

Related to: 10